O-antigen diversity among Acinetobacter baumannii strains from the Czech Republic and Northwestern Europe, as determined by lipopolysaccharide-specific monoclonal antibodies
R. Pantophlet et al., O-antigen diversity among Acinetobacter baumannii strains from the Czech Republic and Northwestern Europe, as determined by lipopolysaccharide-specific monoclonal antibodies, J CLIN MICR, 39(7), 2001, pp. 2576-2580
O-antigen-specific monoclonal antibodies (MAbs) are currently being generat
ed to develop an O-serotyping scheme for the genus Acinetobacter and to pro
vide potent tools to study the diversity of O-antigens among Acinetobacter
strains. In this report, Acinetobacter baumannii strains from the Czech Rep
ublic and from two clonal groups identified in Northwestern Europe (termed
clones I and II) were investigated for their reactivity with a panel of O-a
ntigen-specific MAbs generated against Acinetobacter strains from various s
pecies. The bacteria were characterized for their ribotype, biotype, and an
tibiotic susceptibility and the presence of the 8.7-kb plasmid pAN1, By usi
ng the combination of these typing profiles, the Czech strains could be cla
ssified into four previously defined groups (A, Nemec, L, Janda, O, Melter,
and L, Dijkshoorn, J, med. Microbiol. 48:287-296, 1999): two relatively ho
mogeneous groups of multiresistant strains (termed groups A and R), a heter
ogeneous group of other multiresistant strains, and a group of susceptible
strains. O-antigen reactivity was observed primarily with MAbs generated ag
ainst Acinetobacter calcoaceticus and Acinetobacter baumannii strains. A co
mparison of reaction patterns confirmed the previously hypothesized clonal
relationship between group A and clone I strains, which are also similar in
other properties. The results show that there is limited O-antigen variabi
lity among strains with similar geno- and phenotypic characteristics and ar
e suggestive of a high prevalence of certain A. baumannii serotypes in the
clinical environment. It is also shown that O-antigen-specific MAbs are use
ful for the follow-up of strains causing outbreaks in hospitals.